Brief: India's Balaxi Pharma Sept Quarter Consol Net Profit Rises
Oct 12 (Reuters) - Balaxi Ventures Ltd BALX.NS :
* SEPT QUARTER CONSOL NET PROFIT 101.2 MILLION RUPEES
VERSUS
11.4 MILLION RUPEES YEAR AGO
* SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 603.3
MILLION
RUPEES VERSUS 125.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:
Further company coverage: BALX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Balaxi Pharmaceuticals
See all newsBrief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
India's Balaxi Pharma up after Africa, Latam expansion
Brief: Balaxi Pharmaceuticals Expands Global Reach With Hospital Partnerships In Angola
Brief: Balaxi Pharmaceuticals To Set Up Pharmaceutical Formulation Plant In A Phased Manner
Brief: Balaxi Pharmaceuticals Approves Set Up Of First Pharmaceutical Formulation Plant At Jadcherla, Hyderabad